Status:
WITHDRAWN
Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Major Depression
Eligibility:
All Genders
13-18 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to evaluate whether it is advantageous for adolescents who have recovered from depression after a 6 to 12 week course of antidepressant treatment to stay on the treatment a...
Eligibility Criteria
Inclusion
- Diagnosis of major Depression.
- Age 13-18.
- A score of \> 16 on the 17 item Hamilton Depression Scale or a score of \> 12 on the 17 items plus a score of \>7 on the atypical items.
- Males and females.
- Outpatient at initiation of double blind treatment phase.
- Ability to give informed consent.
Exclusion
- Past or current hypomanic or manic episode.
- Currently meets criteria for a Conduct Disorder.
- Current psychotic symptoms.
- Substance dependence in the last 3 months.
- Significant medical condition that would contraindicate the use of an antidepressant.
- Pregnancy
- Past treatment with Citalopram for major depression
Key Trial Info
Start Date :
September 1 2002
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00249886
Start Date
September 1 2002
End Date
November 1 2006
Last Update
September 19 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5